GlassScriptPhysician profile
Matthew Montgomery
NPI 1689988305
$22,106.51
in general payments reported to CMS, 2019-2025
40 companies · $5,015 in 2025
The $5,015 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,933 · 2020: $404 · 2021: $643 · 2022: $2,685 · 2023: $2,130 · 2024: $3,297 · 2025: $5,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,825 · Travel and Lodging: $2,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,824.96 |
| Travel and Lodging | $2,617.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,840.17 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Navitor |
| Medtronic Vascular, INC. | $3,250.00 | 2019 | |
| Boston Scientific Corporation | $3,105.73 | 2019-2024 | |
| Cvrx, INC. | $1,619.62 | 2022-2025 | Barostim Neo System |
| Abiomed | $1,355.78 | 2019-2025 | Impella |
| Medtronic, INC. | $1,189.19 | 2022-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $512.76 | 2022-2025 | Lifevest |
| Shockwave Medical, INC | $451.83 | 2024-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $396.37 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $395.84 | 2023-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $346.38 | 2020-2025 | Wainua, Farxiga |
| Ancora Heart, INC. | $342.05 | 2024 | Accucinch |
| Stryker Corporation | $311.03 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Actelion Pharmaceuticals US, INC. | $259.73 | 2021-2025 | Uptravi |
| Edwards Lifesciences Corporation | $213.74 | 2023 | Sapien 3 Ultra Resilia |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $210.45 | 2019-2020 | |
| Pfizer INC. | $172.74 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $135.34 | 2024 | Optimizer |
| Zoll Circulation INC | $125.99 | 2023-2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Siemens Medical Solutions USA, INC. | $120.11 | 2020 | |
| Maquet Cardiovascular L.L.C. | $94.84 | 2022 | |
| Astellas Pharma US INC | $89.81 | 2025 | Cresemba |
| Janssen Scientific Affairs, LLC | $67.92 | 2023 | Xarelto |
| Bridgebio Pharma, INC. | $57.00 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.50 | 2022-2023 | Jardiance |
| Atricure, INC. | $52.48 | 2025 | Atriclip Laa Exclusion System |
| Alnylam Pharmaceuticals INC. | $50.97 | 2024-2025 | Amvuttra, Onpattro |
| Briohealth Solutions, INC. | $34.70 | 2025 | Briovad |
| Daxor Corporation | $28.80 | 2023 | Bva-100 |
| One Lambda, INC. | $28.20 | 2024 | |
| Inari Medical, INC. | $27.61 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $26.66 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $26.60 | 2022-2023 | Camzyos |
| Endotronix, INC. | $21.30 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| La Jolla Pharmaceutical Company | $17.17 | 2025 | Giapreza |
| Kamada LTD. | $16.84 | 2025 | |
| Invivyd INC | $15.12 | 2025 | Pemgarda |
| Akcea Therapeutics, INC. | $14.48 | 2021 | |
| Amarin Pharma, INC. | $14.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.62 | 2024 | Livtencity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.